• The Last, Best Chance for Global Polio Eradication?
  After 25 years of remarkable achievements and sometimes harrowing setbacks, a successful conclusion to global polio eradication could finally be within reach.
• Another Candidate HIV Vaccine Fails: We Must Keep Trying
  Yesterday, the National Institute for Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) announced that it was stopping further testing of a candidate HIV vaccine combination (study HVTN 505). While this is a disappointing turn of events, perseverance is needed.
• President’s Malaria Initiative: Big Success from a Quiet Team
  While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results: The President’s Malaria Initiative (PMI).
• Our New iTunesU Course: Global Health Policy in the Second Obama Term
  With the release of our Global Health Policy in the Second Obama Term iTunes University course, we’ve received a few questions about how the course works. We thought it would be helpful to give a quick 101 on the course’s basics.
• Global TB Control Through Partnerships
  On March 21, KNCV honored USAID for the agency’s contribution to the field of global TB control. Dr. Sharon Stash spoke at the awards ceremony and noted options for how the U.S. government can advance these global efforts.
• New Institute of Medicine Report on Illegitimate Drugs: A Moral Tragedy
  The IOM recently released a new report on Countering the Problem of Falsified and Substandard Drugs. It raises important, indeed frightening, concerns about the quality and reliability of medicines in the U.S. and other developed nations, as well as in low- and middle-income countries, and proposes concrete steps in response.
• The New State Department Office of Global Health Diplomacy: A Second Chance to Get Things Right
  The Office of Global Health Diplomacy offers the Obama administration a second chance, after costly stumbles in the first term, to get its global health policy right, especially in improving cross-agency coherence of U.S. international health programs and sharpening the vision for U.S. leadership in global health.

Cervical Cancer and HIV in Women